These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3346407)

  • 81. Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
    Abbott RA; May K; Motley RJ
    Clin Exp Dermatol; 2012 Oct; 37(7):753-4. PubMed ID: 22369225
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

  • 83. Subacute cutaneous lupus erythematosus presenting in twins.
    Montuno MA; Church AA; Schoch JJ; Andrews ID
    Pediatr Dermatol; 2018 Mar; 35(2):e128-e131. PubMed ID: 29436018
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 85. An uncommon cutaneous reaction for a common drug. Diagnosis: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE).
    Kwong HL; Teo RY
    Ann Acad Med Singap; 2014 Aug; 43(8):433-4. PubMed ID: 25244994
    [No Abstract]   [Full Text] [Related]  

  • 86. Efalizumab-induced subacute cutaneous lupus erythematosus.
    Bentley DD; Graves JE; Smith DI; Heffernan MP
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S242-3. PubMed ID: 16631956
    [No Abstract]   [Full Text] [Related]  

  • 87. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Brooke R; Coulson IH; al-Dawoud A
    Br J Dermatol; 1998 Dec; 139(6):1132-3. PubMed ID: 9990400
    [No Abstract]   [Full Text] [Related]  

  • 88. Diuretic-induced renal colic.
    Delevett AF; Recalde M
    JAMA; 1973 Aug; 225(8):992. PubMed ID: 4740567
    [No Abstract]   [Full Text] [Related]  

  • 89. Choroidal effusion as a mechanism for transient myopia induced by hydrochlorothiazide and triamterene.
    Söylev MF; Green RL; Feldon SE
    Am J Ophthalmol; 1995 Sep; 120(3):395-7. PubMed ID: 7661215
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 91. Bullous subacute cutaneous lupus erythematosus.
    Perera GK; Black MM; McGibbon DH
    Clin Exp Dermatol; 2004 May; 29(3):265-7. PubMed ID: 15115507
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Indomethacin and ibuprofen-induced reversible acute renal failure in a patient with systemic lupus erythematosus.
    ter Borg EJ; de Jong PE; Meyer S; van Rijswijk MH; Kallenberg CG
    Neth J Med; 1987 Apr; 30(3-4):181-6. PubMed ID: 3600902
    [No Abstract]   [Full Text] [Related]  

  • 93. Subacute cutaneous lupus erythematosus presenting as erythroderma.
    DeSpain J; Clark DP
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):388-92. PubMed ID: 2970478
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
    Li Z; Jiang N; Xu Y
    Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Risk of kidney stones.
    Ettinger B
    JAMA; 1982 Oct; 248(16):1971. PubMed ID: 7120618
    [No Abstract]   [Full Text] [Related]  

  • 97. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.
    Wong NY; Parsons LM; Trotter MJ; Tsang RY
    BMC Res Notes; 2014 Nov; 7():785. PubMed ID: 25369825
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil.
    Almagro BM; Steyls MC; Navarro NL; Domínguez EG; Acosta EH; Pérez MA; Ceballos EH
    J Clin Oncol; 2011 Jul; 29(20):e613-5. PubMed ID: 21537030
    [No Abstract]   [Full Text] [Related]  

  • 99. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recurrent subacute cutaneous lupus erythematosus following exposure to different drugs.
    Liakou AI; Brunner M; Theodorakis MJ; Makrantonaki E; Zouboulis CC
    Acta Derm Venereol; 2011 Sep; 91(5):586-7. PubMed ID: 21597670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.